Select a section from the left sidebar
Bis-(5Z-7-oxo-caryophyllene)-14-O-ether
- Family: Plantae - Asteraceae
- Kingdom: Plantae
-
Class: Terpenoid
- Subclass: Sesquiterpene
Canonical Smiles | C=C1CC/C=C(\C(=O)CC2[C@@H]1CC2(C)C)/COC/C/1=C/CCC(=C)[C@@H]2C(CC1=O)C(C2)(C)C |
---|---|
InChI | InChI=1S/C30H42O3/c1-19-9-7-11-21(27(31)13-25-23(19)15-29(25,3)4)17-33-18-22-12-8-10-20(2)24-16-30(5,6)26(24)14-28(22)32/h11-12,23-26H,1-2,7-10,13-18H2,3-6H3/b21-11-,22-12-/t23-,24-,25?,26?/m1/s1 |
InChIKey | DVMLAMKRQMRWRG-JIXLKCBHSA-N |
Formula | C30H42O3 |
HBA | 3 |
HBD | 0 |
MW | 450.66 |
Rotatable Bonds | 4 |
TPSA | 43.37 |
LogP | 6.8 |
Number Rings | 4 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Fraction CSP3 | 0.67 |
Exact Mass | 450.31 |
Number of Lipinski Rule Violations | 1 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Pulicaria arabica | Asteraceae | Plantae | 119185 |
Showing of synonyms
Bis-(5Z-7-oxo-caryophyllene)-14-O-ether
- Hafez S, Sarg TM, et al. (1987). Caryophyllene derivatives from Pulicaria arabica. Phytochemistry,1987,26(12),3356-3358. [View]
Pubchem:
162890868
No compound-protein relationship available.
SMILES: C=C1CCC=C(C(=O)CC(C12)CC2)COCC(C(=O)CC(C34)CC3)=CCCC4=C
Level: 1
Mol. Weight: 450.66 g/mol
SMILES: C=C1CCC=CC(=O)CC(C12)CC2
Level: 0
Mol. Weight: 450.66 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -4.67
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.75
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -2.37
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.92
- Plasma Protein Binding
- 98.3
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Substrate
- CYP 2C9 Inhibitor
- Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 11.01
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Toxic
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- 0.38
- Biodegradation
- Safe
- Carcinogenesis
- Toxic
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- 0.49
- Liver Injury II
- Toxic
- hERG Blockers
- Safe
- Daphnia Maga
- 7.07
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -65.52
- Rat (Acute)
- 2.17
- Rat (Chronic Oral)
- 1.96
- Fathead Minnow
- 4.76
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Toxic
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 479.13
- Hydration Free Energy
- -3.26
- Log(D) at pH=7.4
- 5.03
- Log(P)
- 6.22
- Log S
- -6.04
- Log(Vapor Pressure)
- -7.7
- Melting Point
- 92.25
- pKa Acid
- 9.2
- pKa Basic
- 3.19
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | Q0QF01 | SDHA_PIG | Sus scrofa | 3 | 0.9460 |
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | Q0QF01 | SDHA_PIG | Sus scrofa | 3 | 0.9460 |
ADP-ribosylation factor 1 | P84077 | ARF1_HUMAN | Homo sapiens | 2 | 0.7922 |
ADP-ribosylation factor 1 | P84077 | ARF1_HUMAN | Homo sapiens | 2 | 0.7922 |
Type IV / VI secretion system DotU domain-containing protein | Q9KN50 | Q9KN50_VIBCH | Vibrio cholerae serotype O1 | 2 | 0.7574 |
Type IV / VI secretion system DotU domain-containing protein | Q9KN50 | Q9KN50_VIBCH | Vibrio cholerae serotype O1 | 2 | 0.7574 |
Nuclear receptor subfamily 1 group I member 2 | O75469 | NR1I2_HUMAN | Homo sapiens | 3 | 0.7354 |
Nuclear receptor subfamily 1 group I member 2 | O75469 | NR1I2_HUMAN | Homo sapiens | 3 | 0.7354 |
Liver carboxylesterase 1 | P23141 | EST1_HUMAN | Homo sapiens | 2 | 0.7251 |
Liver carboxylesterase 1 | P23141 | EST1_HUMAN | Homo sapiens | 2 | 0.7251 |
Methionine aminopeptidase 2 | P9WK19 | MAP12_MYCTU | Mycobacterium tuberculosis | 3 | 0.7236 |
Methionine aminopeptidase 2 | P9WK19 | MAP12_MYCTU | Mycobacterium tuberculosis | 3 | 0.7236 |
Regulatory protein SdiA | P07026 | SDIA_ECOLI | Escherichia coli | 3 | 0.7124 |
Regulatory protein SdiA | P07026 | SDIA_ECOLI | Escherichia coli | 3 | 0.7124 |
Adenylate cyclase type 5 | P30803 | ADCY5_CANLF | Canis lupus familiaris | 3 | 0.7003 |
Adenylate cyclase type 5 | P30803 | ADCY5_CANLF | Canis lupus familiaris | 3 | 0.7003 |